Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]

Better genetic diagnostics in Ugandan breast cancer patients

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

Diagnosing, treating and managing breast cancer during COVID-19

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Diagnosing, treating and managing breast cancer during COVID-19 ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in...

Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19 ( Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA )

A first-of-its-kind prospective study of a multi-cancer blood test to screen...

Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA

A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer ( Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA )

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk...

Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer ( Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA )

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients...

Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )

New oncogenic drivers in NSCLC

Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands

New oncogenic drivers in NSCLC ( Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands )

The potential of KRAS inhibitors for non-small-cell lung cancer

Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany

The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )

Managing multiple myeloma during the COVID-19 outbreak

Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA

Managing multiple myeloma during the COVID-19 outbreak ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )

Immune checkpoint based approaches in AML and MDS

Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA

Immune checkpoint based approaches in AML and MDS ( Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA )

Treating TRK fusion cancer: Selecting between available agents

Prof Marc Peeters and Dr David Hong

Treating TRK fusion cancer: Selecting between available agents ( Prof Marc Peeters and Dr David Hong )

Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast...

Dr. Geraldo Alves - Hospital Santa Rosa, Brasil

Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer ( Dr. Geraldo Alves - Hospital Santa Rosa, Brasil )

More from ecancer